Skip to main content

Peer Review reports

From: Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

Original Submission
10 Aug 2020 Submitted Original manuscript
4 Sep 2020 Author responded Author comments - Wolfgang M Brueckl
Resubmission - Version 2
4 Sep 2020 Submitted Manuscript version 2
10 Nov 2020 Author responded Author comments - Wolfgang M Brueckl
27 Sep 2020 Reviewed Reviewer Report
24 Oct 2020 Reviewed Reviewer Report
Resubmission - Version 3
10 Nov 2020 Submitted Manuscript version 3
Publishing
25 Nov 2020 Editorially accepted
3 Dec 2020 Article published 10.1186/s12885-020-07690-8

You can find further information about peer review here.

Back to article page
\